Skip to main content

Skin Substitution Products is the largest segment driving the growth of U.S. Acellular Dermal Matrices Market

U.S. Acellular Dermal Matrices Market

The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Acellular dermal matrices are used in tissue regeneration as skin substitutes. They are derived from human or animal dermis tissues and are used routinely in plastic and reconstructive surgeries.

Market key trends:-

One of the key trends in the U.S. acellular dermal matrices market is the growing demand for advanced wound care products. With rising incidences of diabetic foot ulcers and pressure ulcers, there is increasing demand for acellular dermal matrices for wound closure and healing. These dermal matrices help regenerate tissue and promotes wound healing. Additionally, technologically advanced acellular matrices that mimic natural extracellular matrix are gaining traction. Products infused with growth factors or cells expedite wound healing.

Market key trends:-

The U.S. acellular dermal matrices market has been witnessing high growth over the past few years. One of the key trends driving the growth of this market is the increasing use of acellular dermal matrices for hernia repair surgeries. Acellular dermal matrices are widely used in hernia repair procedures due to their ability to reinforce and strengthen weak tissue areas. Moreover, with rising geriatric population and increasing incidence of hernias, the demand for hernia repair surgeries using acellular dermal matrices is expected to rise in the country.

SWOT Analysis

  • Strength: Acellular dermal matrices offer effective tissue reinforcement and reduce postoperative hernia recurrence rates. They help integrate well with the native tissue.
  • Weakness: High costs associated with acellular dermal matrices can limit their adoption.
  • Opportunity: Growing geriatric population prone to hernias creates growth opportunities. Increasing awareness about benefits of acellular dermal matrices also presents opportunities.
  • Threats: Stringent regulatory approvals and recalls of dermal matrix products pose threats. Reimbursement issues also restrict market growth.

Key Takeaways:-

The U.S. Acellular Dermal Matrices Market Size was valued at US$ 2783.32 Mn in 2023 and is expanding at a CAGR of 3.8% during the forecast period.

The rising incidence of hernias coupled with the growing geriatric population in the U.S. is a major factor driving the demand for acellular dermal matrices in the country. According to the National Center for Biotechnology Information (NCBI), groin hernias account for 75% of all hernias in the U.S., with over 1 million repairs done every year.

Regionally, the South region dominated the U.S. acellular dermal matrices market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major market players andavailability of advanced healthcare facilities in states such as Florida, Texas and North Carolina.

Key players operating in the U.S. Acellular Dermal Matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

 

Read More - https://www.insightprobing.com/u-s-acellular-dermal-matrices-market-forecasts-and-outlook-analysis/

Comments

Popular posts from this blog

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...